Search research articles
Contact Us
Filters
Showing results (71-80 of 541) with videos related to
Page
of 55
Sort By:
Nature Clinical Practice. Urology
|
February 9, 2007
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer
Sunil Sudarshan, Peter A Pinto, Len Neckers, et al.
Targeted Oncology
|
August 4, 2010
Targeted therapies for non-clear renal cell carcinoma
Eric A Singer, Gennady Bratslavsky, W Marston Linehan, et al.
Urologic Oncology
|
March 17, 2009
The clinical implications of the genetics of renal cell carcinoma
Inger Rosner, Gennady Bratslavsky, Peter A Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2015
New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease
Ramaprasad Srinivasan, Christopher J Ricketts, Carole Sourbier, et al.
Urology
|
September 14, 2010
Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy?
Brian R Lane, Amr F Fergany, W Marston Linehan, et al.
Familial Cancer
|
May 25, 2013
Diagnosis and management of BHD-associated kidney cancer
Lambros Stamatakis, Adam R Metwalli, Lindsay A Middelton, et al.
Cancer
|
November 14, 2012
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics
Wong-Ho Chow, Brian Shuch, W Marston Linehan, et al.
The Journal of Urology
|
December 13, 2002
A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder
Edward M Uchio, W Marston Linehan, William D Figg, et al.
Current Urology Reports
|
December 4, 2010
Impact of genetics on the diagnosis and treatment of renal cancer
Eric A Singer, Gennady Bratslavsky, Lindsay Middelton, et al.
BJU International
|
April 20, 2007
Genetic basis of kidney cancer: a model for developing molecular-targeted therapies
Manish A Vira, Kristian R Novakovic, Peter A Pinto, et al.
Page
of 55
Search research articles
Search
Showing results (71-80 of 541) with videos related to
Sort By:
Page
of 55
Nature Clinical Practice. Urology
|
February 9, 2007
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer
Sunil Sudarshan, Peter A Pinto, Len Neckers, et al.
Targeted Oncology
|
August 4, 2010
Targeted therapies for non-clear renal cell carcinoma
Eric A Singer, Gennady Bratslavsky, W Marston Linehan, et al.
Urologic Oncology
|
March 17, 2009
The clinical implications of the genetics of renal cell carcinoma
Inger Rosner, Gennady Bratslavsky, Peter A Pinto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 8, 2015
New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease
Ramaprasad Srinivasan, Christopher J Ricketts, Carole Sourbier, et al.
Urology
|
September 14, 2010
Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy?
Brian R Lane, Amr F Fergany, W Marston Linehan, et al.
Familial Cancer
|
May 25, 2013
Diagnosis and management of BHD-associated kidney cancer
Lambros Stamatakis, Adam R Metwalli, Lindsay A Middelton, et al.
Cancer
|
November 14, 2012
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics
Wong-Ho Chow, Brian Shuch, W Marston Linehan, et al.
The Journal of Urology
|
December 13, 2002
A phase I study of intravesical suramin for the treatment of superficial transitional cell carcinoma of the bladder
Edward M Uchio, W Marston Linehan, William D Figg, et al.
Current Urology Reports
|
December 4, 2010
Impact of genetics on the diagnosis and treatment of renal cancer
Eric A Singer, Gennady Bratslavsky, Lindsay Middelton, et al.
BJU International
|
April 20, 2007
Genetic basis of kidney cancer: a model for developing molecular-targeted therapies
Manish A Vira, Kristian R Novakovic, Peter A Pinto, et al.
Page
of 55